Medicus Pharma Ltd.
MDCX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001997296
No open-market purchases or sales by Medicus Pharma Ltd. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesMDCXW
13F holders, Q2 2026
Institutional positions in Medicus Pharma Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +2 vs. Q1 2026
- Shares held
- 2.62M
- +302.3K (+13.0%) vs. Q1 2026
- Total value
- $1.18M
- +$878.1K (+291.2%) vs. Q1 2026
- New holders
- 9
- 6 more added
- Sold out
- 7
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $1.18M |
| Q1 2026 | 21 | $301.6K |
| Q4 2025 | 21 | $6.03M |
| Q3 2025 | 20 | $4.91M |
| Q2 2025 | 21 | $6.60M |
| Q1 2025 | 7 | $11.4M |
| Q4 2024 | 3 | $3.74M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Medicus Pharma Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hazlett, Burt & Watson, Inc. | 425 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,055 | $0 | 0.00% | +1,055 | New |
| Wells Fargo & Company | 200 | $89 | 0.00% | +125+166.7% | Added |
| Jones Financial Companies LLLP | 400 | $183 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,022 | $456 | 0.00% | −4,446−81.3% | Reduced |
| Advisor Group Holdings, Inc. | 7,500 | $3.38K | 0.00% | −1,000−11.8% | Reduced |
| Foundations Investment Advisors, LLC | 11,000 | $4.91K | 0.00% | +11,000 | New |
| StoneX Group Inc. | 17,066 | $6.37K | 0.00% | +1,897+12.5% | Added |
| Marathon Capital Management | 15,500 | $6.92K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 17,512 | $7.82K | 0.00% | +1,900+12.2% | Added |
| Stratos Wealth Partners, LTD. | 20,950 | $9.35K | 0.00% | +20,950 | New |
| Smithfield Trust Co | 24,614 | $11.0K | 0.00% | +13,134+114.4% | Added |
| Citadel Advisors LLC | 25,102 | $11.2K | 0.00% | +7,278+40.8% | Added |
| Bryn Mawr Trust Co | 25,622 | $11.4K | 0.00% | −25,622−50.0% | Reduced |
| JPMorgan Chase & Co | 25,622 | $12.5K | 0.00% | +25,622 | New |
| Stifel Financial Corp | 30,000 | $13.4K | 0.00% | +30,000 | New |
| Susquehanna International Group, LLP | 31,462 | $14.0K | 0.00% | +31,462 | New |
| May Hill Capital, LLC | 50,622 | $22.6K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 52,643 | $23.5K | 0.00% | +4,500+9.3% | Added |
| Sterling Investment Advisors, Ltd. | 100,000 | $44.6K | 0.01% | +100,000 | New |
| XTX Topco Ltd | 243,362 | $108.6K | 0.00% | +243,362 | New |
| Jane Street Group, LLC | 333,673 | $148.9K | 0.00% | +333,673 | New |
| Interchange Capital Partners, LLC | 1,586,871 | $718.4K | 0.14% | −75,000−4.5% | Reduced |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −240,055−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −74,045−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −40,441−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −37,294−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −15,617−100.0% | Sold out |
| Brave Asset Management Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −121−100.0% | Sold out |